Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Terminated 3

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Squamous Cell Carcinoma of Head and Neck 4Brain Neoplasms 4Glioma 3Glioblastoma 3Carcinoma, Hepatocellular 3Neoplasms 2Head and Neck Neoplasms 2Skin Neoplasms 1Sarcoma 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Liver Cirrhosis 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Astrocytoma 1

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × fluoromisonidazole × Clear all
NCT01246869 2024-10-01

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

University of Utah

Phase 1 Terminated
2 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neoplasms

NCT03573986 2020-02-17

Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment

Abramson Cancer Center at Penn Medicine

Phase 1 Terminated
2 enrolled
CNS

Glioblastoma

NCT01868906 2018-08-24

FMISOPETSCS

Dr. Negrin University Hospital

Phase 2 Terminated
6 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡